These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 31981)

  • 1. Characterization of macrophage activation factor, a lymphokine that causes macrophages to become cytotoxic for tumor cells.
    Leonard EJ; Ruco LP; Meltzer MS
    Cell Immunol; 1978 Dec; 41(2):347-57. PubMed ID: 31981
    [No Abstract]   [Full Text] [Related]  

  • 2. Macrophage activation for tumor cytotoxicity: increased lymphokine responsiveness of peritoneal macrophages during acute inflammation.
    Ruco LP; Meltzer MS
    J Immunol; 1978 Mar; 120(3):1054-62. PubMed ID: 632578
    [No Abstract]   [Full Text] [Related]  

  • 3. Macrophage activation for tumor cytotoxicity: analysis of cellular lipid and fatty acid content during lymphokine activation.
    Schlager SI; Meltzer MS
    J Reticuloendothel Soc; 1981 Mar; 29(3):227-40. PubMed ID: 7218233
    [No Abstract]   [Full Text] [Related]  

  • 4. Modulation of the tumoricidal function of activated macrophages by bacterial endotoxin and mammalian macrophage activation factor (s).
    Hibbs JB; Weinberg JB; Chapman HA
    Adv Exp Med Biol; 1979; 121B():433-53. PubMed ID: 232620
    [No Abstract]   [Full Text] [Related]  

  • 5. Macrophage activation for tumor cytotoxicity: development of macrophage cytotoxic activity requires completion of a sequence of short-lived intermediary reactions.
    Ruco LP; Meltzer MS
    J Immunol; 1978 Nov; 121(5):2035-42. PubMed ID: 712076
    [No Abstract]   [Full Text] [Related]  

  • 6. Macrophage activation for tumor cytotoxicity: tumoricidal activity by macrophages from C3H/HeJ mice requires at least two activation stimuli.
    Ruco LP; Meltzer MS
    Cell Immunol; 1978 Nov; 41(1):35-51. PubMed ID: 363288
    [No Abstract]   [Full Text] [Related]  

  • 7. Interferon-induced enhancement of macrophage-mediated tumor cytolysis and its difference from activation by lymphokines.
    Boraschi D; Tagliabue A
    Eur J Immunol; 1981 Feb; 11(2):110-4. PubMed ID: 6163639
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Macrophage activation for tumor cytotoxicity: genetic variation in macrophage tumoricidal capacity among mouse strains.
    Boraschi D; Meltzer MS
    Cell Immunol; 1979 Jun; 45(1):188-94. PubMed ID: 378423
    [No Abstract]   [Full Text] [Related]  

  • 9. Studies on macrophage-activating factor (MAF) in antitumor immune responses. I. Tumor-specific Lyt-1+2- T cells are required for producing MAF able to generate cytolytic as well as cytostatic macrophages.
    Nakajima H; Fujiwara H; Takai Y; Izumi Y; Sano S; Tsuchida T; Hamaoka T
    J Immunol; 1985 Sep; 135(3):2199-205. PubMed ID: 3894520
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vitro studies on the tumour cytotoxicity of normal, stimulated and immunologically activated mouse macrophages.
    Hansen JG; Bennedsen J; Rhodes JM; Larsen SO
    Acta Pathol Microbiol Immunol Scand C; 1982 Feb; 90(1):27-32. PubMed ID: 7080837
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Macrophage activation for tumor cytotoxicity: characterization of priming and trigger signals during lymphokine activation.
    Meltzer MS
    J Immunol; 1981 Jul; 127(1):179-83. PubMed ID: 7240741
    [No Abstract]   [Full Text] [Related]  

  • 12. Role of macrophage lipids in regulating tumoricidal activity. II. Internal genetic and external physiologic regulatory factors controlling macrophage tumor cytotoxicity also control characteristic lipid changes associated with tumoricidal cells.
    Schlager SI; Meltzer MS
    Cell Immunol; 1983 Aug; 80(1):10-9. PubMed ID: 6872005
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Activation of tumoricidal properties in mouse macrophages by lymphokines encapsulated in liposomes.
    Poste G; Kirsh R; Fogler WE; Fidler IJ
    Cancer Res; 1979 Mar; 39(3):881-92. PubMed ID: 427777
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vitro induction of tumoricidal and suppressor macrophages by lymphokines: possible feedback regulation.
    Taramelli D; Holden HT; Varesio L
    J Immunol; 1981 Jun; 126(6):2123-8. PubMed ID: 6453155
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Macrophage activation for tumor cytotoxicity: induction of tumoricidal macrophages by supernatants of PPD-stimulated Bacillus Calmette-Guérin-immune spleen cell cultures.
    Ruco LP; Meltzer MS
    J Immunol; 1977 Sep; 119(3):889-96. PubMed ID: 330759
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Induction of specific macrophage cytotoxicity.
    De Weger RA; Den Otter W
    Methods Enzymol; 1986; 132():531-6. PubMed ID: 3547024
    [No Abstract]   [Full Text] [Related]  

  • 17. Macrophage activation to kill Leishmania tropica: characterization of a T cell-derived factor that suppresses lymphokine-induced intracellular destruction of amastigotes.
    Nacy CA
    J Immunol; 1984 Jul; 133(1):448-53. PubMed ID: 6202789
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lymphokine-induced cytotoxicity: characterization of effectors, precursors, and regulatory ancillary cells.
    Ting CC; Yang SS; Hargrove ME
    Cancer Res; 1986 Feb; 46(2):513-8. PubMed ID: 3079663
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Relationship between murine macrophage Fc receptor-mediated phagocytic function and competency for activation for non-specific tumor cytotoxicity.
    Leu RW; Rummage JA; Rahimi MB; Herriott MJ
    Immunobiology; 1986 Apr; 171(3):220-33. PubMed ID: 3519439
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Macrophage activation for tumor cytotoxicity: control of macrophage tumoricidal capacity by the LPS gene.
    Ruco LP; Meltzer MS; Rosenstreich DL
    J Immunol; 1978 Aug; 121(2):543-8. PubMed ID: 681749
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.